摘要
目的探讨心肺超声在参麦注射液联合芪参益气滴丸治疗扩张型心肌病(DCM)患者疗效评估中的应用效果。方法选取2019年6月至2021年4月江西省人民医院收治的180例DCM患者作为研究对象,采用随机数字表法分为观察A组、观察B组及对照组,每组各60例。观察A组在常规治疗的基础上给予参麦注射液联合芪参益气滴丸治疗;观察B组在常规治疗的基础上给予芪参益气滴丸治疗;对照组给予常规治疗。比较三组患者治疗6个疗程后的临床疗效;同时比较治疗前后三组患者的各项心肺超声参数及肺超声B线积分。结果治疗6个疗程后,观察A组的治疗总有效率高于对照组与观察B组,差异有统计学意义(P<0.05)。观察B组与对照组的治疗总有效率比较,差异无统计学意义(P>0.05)。治疗后观察A组、观察B组患者的左心室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、左心室后壁运动延迟时间(SPWMD)、心胸比例(CTR)和肺动脉收缩压(PASP)均低于对照组,左室射血分数(LVEF)高于对照组,且治疗后观察A组患者的LVESD、LVEDD、SPWMD、CTR、PASP均低于观察B组,LVEF高于观察B组,差异有统计学意义(P<0.05)。治疗前,三组患者的肺超声B线积分比较,差异无统计学意义(P>0.05);治疗后,观察A组、观察B组患者的肺超声B线积分低于对照组,且观察A组患者的肺超声B线积分低于观察B组,差异有统计学意义(P<0.05)。结论心肺超声能评价参麦注射液联合芪参益气滴丸治疗DCM患者的疗效。
Objective To investigate the application effect of cardiopulmonary ultrasound in evaluating the curative effect of Shenmai Injection combined with Qishen Yiqi Dropping Pills on patients with dilated cardiomyopathy(DCM).Methods A total of 180 patients with DCM admitted to Jiangxi Provincial People′s Hospital from June 2019 to April 2021 were selected as the research objects,and they were divided into observation group A,observation group B,and control group according to the random number table method,with 60 patients in each group.Patients in observation group A were treated with Shenmai Injection combined with Qishen Yiqi Dropping Pills on the basis of conventional treatment.Patients in observation group B were treated with Qishen Yiqi Dropping Pills on the basis of conventional treatment,and patients in control group were given conventional treatment.The three groups were compared in terms of the clinical effect after 6 courses of treatment,the cardiopulmonary ultrasound parameters and lung ultrasound B-line scores before and after treatment.Results After 6 courses of treatment,the total treatment response rate in observation group A was higher than those in control group and observation group B,and the differences were statistically significant(P<0.05).There was no statistically significant difference in the total treatment response rate between observation group B and the control group(P>0.05).The left ventricular end systolic diameter(LVESD),left ventricular and diastolic diameter(LVEDD),septal-to-posterior wall motion delay(SPWMD),cardiothoracic ratio(CTR)and pulmonary artery systolic pressure(PASP)after treatment in observation group A and observation group B were lower than those in the control group,and left ventricular ejection fraction(LVEF)was higher than that in the control group,the LVESD,LVEDD,SPWMD,CTR and PASP in observation group A were lower than those in observation group B, and LVEF was higher than that in observation group B, the differences were statistically significant (P<0.05). There wa
作者
崔亮
CUI Liang(Department of Ultrasound,Jiangxi Provincial People′s Hospital,Jiangxi Province,Nanchang330006,China)
出处
《中国当代医药》
CAS
2022年第21期9-13,共5页
China Modern Medicine
基金
江西省中医药管理局科技计划项目(2020A0086)。
关键词
心肺超声
参麦注射液
芪参益气滴丸
扩张型心肌病
治疗效果
评估价值
Cardiopulmonary ultrasound
Shenmai Injection
Qishen Yiqi Dropping Pills
Dilated cardiomyopathy
Curative effect
Evaluation value
